Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Recruiting 2

Sponsor Class

OTHER 2OTHER_GOV 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Breast Neoplasms 2321Neoplasms 1683Prostatic Neoplasms 1180Lung Neoplasms 911Colorectal Neoplasms 876Carcinoma, Non-Small-Cell Lung 851Leukemia, Myeloid, Acute 587Pancreatic Neoplasms 568Multiple Myeloma 542Carcinoma, Hepatocellular 511Brain Neoplasms 510Neoplasm Metastasis 457Head and Neck Neoplasms 454Melanoma 410Ovarian Neoplasms 404Glioblastoma 398Precursor Cell Lymphoblastic Leukemia-Lymphoma 390Stomach Neoplasms 370Uterine Cervical Neoplasms 357Squamous Cell Carcinoma of Head and Neck 357Rectal Neoplasms 337Recurrence 332Hematologic Neoplasms 324Sarcoma 322Colonic Neoplasms 317Lymphoma 311Triple Negative Breast Neoplasms 284Urinary Bladder Neoplasms 279Carcinoma, Renal Cell 279Glioma 278

Interventions

Tablets 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Localized Prostate Cancer × 1 year × Clear all
NCT06825091 2026-06-02

ASPIRE

University Health Network, Toronto

Phase 3 Recruiting
320 enrolled
Genitourinary

Localized Prostate Cancer

NCT06966778 2026-03-16

Oxybutynin ER to Promote Early Continence Recovery After Robotic Prostatectomy: A Randomized Controlled Trial

National Taiwan University Hospital

Phase NA Recruiting
135 enrolled
Genitourinary

Localized Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡